178 related articles for article (PubMed ID: 21623751)
1. Increases in invasive melanoma in England, 1979-2006, by anatomical site.
Wallingford SC; Alston RD; Birch JM; Green AC
Br J Dermatol; 2011 Oct; 165(4):859-64. PubMed ID: 21623751
[TBL] [Abstract][Full Text] [Related]
2. Trends in the incidence of cutaneous malignant melanomas in the south east of England, 1960-1998.
Newnham A; Møller H
J Public Health Med; 2002 Dec; 24(4):268-75. PubMed ID: 12546203
[TBL] [Abstract][Full Text] [Related]
3. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site.
Chen YT; Zheng T; Holford TR; Berwick M; Dubrow R
Cancer Causes Control; 1994 Jul; 5(4):341-50. PubMed ID: 8080946
[TBL] [Abstract][Full Text] [Related]
4. Changes in the site distribution of common melanoma subtypes in Queensland, Australia over time: implications for public health campaigns.
Youl PH; Youlden DR; Baade PD
Br J Dermatol; 2013 Jan; 168(1):136-44. PubMed ID: 22612718
[TBL] [Abstract][Full Text] [Related]
5. Changing epidemiology and age-specific incidence of cutaneous malignant melanoma in England: An analysis of the national cancer registration data by age, gender and anatomical site, 1981-2018.
Memon A; Bannister P; Rogers I; Sundin J; Al-Ayadhy B; James PW; McNally RJQ
Lancet Reg Health Eur; 2021 Mar; 2():100024. PubMed ID: 34557790
[TBL] [Abstract][Full Text] [Related]
6. Melanoma in Western Australia 1975-76 to 1980-81: trends in demographic and pathological characteristics.
English DR; Heenan PJ; Holman CD; Armstrong BK; Blackwell JB; Kelsall GR; Matz LR; Singh A; ten Seldam RE
Int J Cancer; 1986 Feb; 37(2):209-15. PubMed ID: 3943920
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954-2008.
Robsahm TE; Bergva G; Hestvik UE; Møller B
Melanoma Res; 2013 Feb; 23(1):70-8. PubMed ID: 23222548
[TBL] [Abstract][Full Text] [Related]
9. Does relative melanoma distribution by body site 1960-2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population?
Dal H; Boldemann C; Lindelöf B
Eur J Dermatol; 2007; 17(5):428-34. PubMed ID: 17673388
[TBL] [Abstract][Full Text] [Related]
10. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
[TBL] [Abstract][Full Text] [Related]
11. Regional melanoma incidence in England, 1996-2006: reversal of north-south latitude trends among the young female population.
Wallingford SC; Alston RD; Birch JM; Green AC
Br J Dermatol; 2013 Oct; 169(4):880-8. PubMed ID: 23746131
[TBL] [Abstract][Full Text] [Related]
12. Comparison of melanoma incidence and trends among youth under 25 years in Australia and England, 1990-2010.
Wallingford SC; Iannacone MR; Youlden DR; Baade PD; Ives A; Verne J; Aitken JF; Green AC
Int J Cancer; 2015 Nov; 137(9):2227-33. PubMed ID: 25960371
[TBL] [Abstract][Full Text] [Related]
13. Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989-2011.
Bay C; Kejs AM; Storm HH; Engholm G
Cancer Epidemiol; 2015 Feb; 39(1):1-7. PubMed ID: 25468643
[TBL] [Abstract][Full Text] [Related]
14. Site-specific risk of cutaneous malignant melanoma and pattern of sun exposure in New Zealand.
Bulliard JL
Int J Cancer; 2000 Mar; 85(5):627-32. PubMed ID: 10699940
[TBL] [Abstract][Full Text] [Related]
15. Descriptive epidemiology of skin cancer in the Swiss Canton of Vaud.
Levi F; La Vecchia C; Te VC; Mezzanotte G
Int J Cancer; 1988 Dec; 42(6):811-6. PubMed ID: 3192322
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
Katalinic A; Kunze U; Schäfer T
Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
[TBL] [Abstract][Full Text] [Related]
17. Fatal melanoma of the lower limbs and other sites: an epidemiologic study.
Lee JA
J Natl Cancer Inst; 1970 Feb; 44(2):257-61. PubMed ID: 11515067
[No Abstract] [Full Text] [Related]
18. In situ and invasive melanoma in a high-risk, New Zealand, population: A population-based study.
Elwood JM; Kim SJ; Ip KH; Oakley A; Rademaker M
Australas J Dermatol; 2019 Feb; 60(1):38-44. PubMed ID: 30051460
[TBL] [Abstract][Full Text] [Related]
19. Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009.
Reyes E; Uribe C; de Vries E
Int J Dermatol; 2018 Jan; 57(1):21-27. PubMed ID: 29231241
[TBL] [Abstract][Full Text] [Related]
20. Trends in incidence of cutaneous malignant melanoma in Canada: 1992-2010 versus 2011-2015.
Ghazawi FM; Le M; Alghazawi N; Rahme E; Moreau L; Netchiporouk E; Zubarev A; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
J Am Acad Dermatol; 2019 Apr; 80(4):1157-1159. PubMed ID: 30395916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
